Advanced search
Publication Cover
Leukemia & Lymphoma Volume 62, 2021 - Issue 14
Submit an article Journal homepage
204
Views
4
CrossRef citations to date
0
Altmetric
Letters to the Editor

Acute leukemia and SARS-CoV-2 infection: clinical characteristics and risk factors for mortality

Mirjana Mitrovica Clinic of Hematology, Clinical Center of Serbia, Belgrade, Serbia;b Faculty of Medicine, University of Belgrade, Belgrade, SerbiaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-8313-3754View further author information
ORCID Icon,
Nikola Pantica Clinic of Hematology, Clinical Center of Serbia, Belgrade, SerbiaView further author information
,
Nikica Sabljica Clinic of Hematology, Clinical Center of Serbia, Belgrade, SerbiaView further author information
,
Miodrag Vucicc Clinic of Hematology, Clinical Center of Nis, Nis, Serbia;d Faculty of Medicine, University of Nis, Nis, SerbiaView further author information
,
Zoran Bukumirice Institute for Medical Statistics and Informatics, Faculty of Medicine, University of Belgrade, Belgrade, SerbiaView further author information
,
Marijana Virijevica Clinic of Hematology, Clinical Center of Serbia, Belgrade, Serbia;b Faculty of Medicine, University of Belgrade, Belgrade, SerbiaView further author information
,
Zlatko Pravdica Clinic of Hematology, Clinical Center of Serbia, Belgrade, SerbiaView further author information
,
Jovan Rajica Clinic of Hematology, Clinical Center of Serbia, Belgrade, SerbiaView further author information
,
Milena Todorovic-Balinta Clinic of Hematology, Clinical Center of Serbia, Belgrade, Serbia;b Faculty of Medicine, University of Belgrade, Belgrade, SerbiaView further author information
,
Ana Vidovica Clinic of Hematology, Clinical Center of Serbia, Belgrade, Serbia;b Faculty of Medicine, University of Belgrade, Belgrade, SerbiaView further author information
&
Nada Suvajdzic-Vukovica Clinic of Hematology, Clinical Center of Serbia, Belgrade, Serbia;b Faculty of Medicine, University of Belgrade, Belgrade, SerbiaView further author information
 show all
Pages 3516-3520 | Received 19 Mar 2021, Accepted 24 Jul 2021, Published online: 13 Aug 2021

References

  • Passamonti F, Cattaneo C, Arcaini L, et al. Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study. Lancet Haematol. 2020;7(10):e737–e745.
  • García-Suárez J, de la Cruz J, Cedillo Á, et al. Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: lessons from a large population-based registry study. J Hematol Oncol. 2020;13(1):133
  • Recommendations for the management of patients with AML during the COVID19 outbreak: a statement from the NCRI AML Working Party. Version 4.0 [Internet]. Birmingham (UK). 2020. Jun 16. [cited 2021 Jan 28]. Available from: http://www.cureleukaemia.co.uk/media/upload/files/aml-covid-v4.0%281%29.pdf.
  • Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the world health organization classification of myeloid neoplasms and acute leukemia. Blood. 2016; 127(20):2391–2405.
  • Pelemis M, Stevanovic G, Turklov V, et al. National protocol for COVID-19 patients treatment, version 10. Belgrade (Serbia): Ministry of Health Republic of Serbia; 2020. [Internal report]. Unpublished.
  • World Health Organization. Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected: interim guidance. Geneva (Switzerland): WHO 2020. May 27 [cited 2021 Jan 20]. Available from: https://www.who.int/publications/i/item/clinical-management-of-covid-19
  • Barranco R, Vallega Bernucci Du Tremoul L, Ventura F. Hospital-Acquired SARS-Cov-2 infections in patients: inevitable conditions or medical malpractice? Int J Environ Res Public Health. 2021;18(2):489.
  • Bhogal T, Khan UT, Lee R, et al. Haematological malignancy and nosocomial transmission are associated with an increased risk of death from COVID-19: results of a multi-center UK cohort. Leuk Lymphoma. 2021;62(7):1682–1616.
  • Petrilli CM, Jones SA, Yang J, et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York city: prospective cohort study. BMJ. 2020;369:m1966.
  • Lee LY, Cazier JB, Angelis V, et al. COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study. Lancet. 2020;395(10241):1919–1926.
  • Cattaneo C, Daffini R, Pagani C, et al. Clinical characteristics and risk factors for mortality in patients with hematologic patients affected by COVID-19. Cancer. 2020;126(23):5069–5076.
  • Martín-Moro F, Marquet J, Piris M, et al. Survival study of hospitalised patients with concurrent COVID-19 and haematological malignancies. Br J Haematol. 2020;190(1):e16–e20.
  • Röllig C, Kramer M, Schliemann C, et al. Time from diagnosis to treatment does not affect outcome in intensively treated patients with newly diagnosed acute myeloid leukemia. Blood. 2019;134(Supplement_1):13–13.
  • World Health Organization. Solidarity Therapeutics Trial produces conclusive evidence on the effectiveness of repurposed drugs for COVID-19 in record time. [cited 2021 Jan 28]. Available from: https://www.who.int/news/item/15-10-2020-solidarity-therapeutics-trial-produces-conclusive-evidence-on-the-effectiveness-of-repurposed-drugs-for-covid-19-in-record-time.
  • O'Nions J, Muir L, Zheng J, et al. SARS-CoV-2 antibody responses in patients with acute leukaemia. Leukemia. 2021;35(1):289–292.
  • Roeker LE, Knorr DA, Pessin MS, et al. Anti-SARS-CoV-2 antibody response in patients with chronic lymphocytic leukemia. Leukemia. 2020;34(11):3047–3049.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.